Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Research & Development (2016 - 2025)

Wave Life Sciences' Research & Development history spans 11 years, with the latest figure at $52.8 million for Q4 2025.

  • For Q4 2025, Research & Development rose 18.3% year-over-year to $52.8 million; the TTM value through Dec 2025 reached $182.8 million, up 14.46%, while the annual FY2025 figure was $182.8 million, 14.46% up from the prior year.
  • Research & Development reached $52.8 million in Q4 2025 per WVE's latest filing, up from $45.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $52.8 million in Q4 2025 to a low of $25.8 million in Q4 2021.
  • Average Research & Development over 5 years is $35.5 million, with a median of $33.4 million recorded in 2021.
  • Peak YoY movement for Research & Development: decreased 18.87% in 2021, then soared 31.02% in 2024.
  • A 5-year view of Research & Development shows it stood at $25.8 million in 2021, then grew by 20.64% to $31.1 million in 2022, then increased by 9.64% to $34.1 million in 2023, then skyrocketed by 31.02% to $44.6 million in 2024, then grew by 18.3% to $52.8 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Research & Development are $52.8 million (Q4 2025), $45.9 million (Q3 2025), and $43.5 million (Q2 2025).